Amlodipine Besylate

Amlodipine is a widely used generic pharmaceutical medication primarily prescribed to treat high blood pressure (hypertension) and chest pain (angina). Originally developed and patented by the American pharmaceutical giant Pfizer, the drug was marketed under the brand name Norvasc after receiving FDA approval in 1992. Following the expiration of the original patent in 2007, Amlodipine became available as a generic medication, leading to its production by numerous pharmaceutical manufacturers worldwide.

Today, the manufacturing of Amlodipine takes place in multiple countries, with significant production hubs in India, China, the United States, and Germany. Large generic firms such as Teva, Sandoz, and Viatris maintain global supply chains for this essential medicine. Because it is a generic drug, it does not have a single 'ultimate owner' in the traditional sense; rather, the rights to manufacture and sell it are held by any licensed pharmaceutical company that meets regulatory standards.

The brand origin is deeply rooted in the United States, where Pfizer's research and development teams first synthesized the chemical compound. While Pfizer remains a major player through its legacy brands and off-patent divisions, the market is now dominated by high-volume generic producers that ensure the medication remains affordable and accessible to patients across the globe. Ownership structures vary significantly depending on which specific generic brand a consumer purchases.